BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 17089002)

  • 21. Loss of XIAP sensitizes colon cancer cells to PPARgamma independent antitumor effects of troglitazone and 15-PGJ2.
    Qiao L; Dai Y; Gu Q; Chan KW; Ma J; Lan HY; Zou B; Rocken C; Ebert MP; Wong BC
    Cancer Lett; 2008 Sep; 268(2):260-71. PubMed ID: 18477501
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Peroxisome proliferator-activated receptor alpha, delta, gamma1 and gamma2 expressions are present in human monocyte-derived dendritic cells and modulate dendritic cell maturation by addition of subtype-specific ligands.
    Jakobsen MA; Petersen RK; Kristiansen K; Lange M; Lillevang ST
    Scand J Immunol; 2006 May; 63(5):330-7. PubMed ID: 16640656
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PPARgamma agonists attenuate proliferation and modulate Wnt/beta-catenin signalling in melanoma cells.
    Smith AG; Beaumont KA; Smit DJ; Thurber AE; Cook AL; Boyle GM; Parsons PG; Sturm RA; Muscat GE
    Int J Biochem Cell Biol; 2009 Apr; 41(4):844-52. PubMed ID: 18822385
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Disruption of ERalpha signalling pathway by PPARgamma agonists: evidences of PPARgamma-independent events in two hormone-dependent breast cancer cell lines.
    Lecomte J; Flament S; Salamone S; Boisbrun M; Mazerbourg S; Chapleur Y; Grillier-Vuissoz I
    Breast Cancer Res Treat; 2008 Dec; 112(3):437-51. PubMed ID: 18204896
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cotranscription and intergenic splicing of the PPARG and TSEN2 genes in cattle.
    Roux M; Levéziel H; Amarger V
    BMC Genomics; 2006 Apr; 7():71. PubMed ID: 16595010
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rosiglitazone increases PPARgamma in renal tubular epithelial cells and protects against damage by hydrogen peroxide.
    Sommer M; Wolf G
    Am J Nephrol; 2007; 27(4):425-34. PubMed ID: 17622750
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The organization, promoter analysis, and expression of the human PPARgamma gene.
    Fajas L; Auboeuf D; Raspé E; Schoonjans K; Lefebvre AM; Saladin R; Najib J; Laville M; Fruchart JC; Deeb S; Vidal-Puig A; Flier J; Briggs MR; Staels B; Vidal H; Auwerx J
    J Biol Chem; 1997 Jul; 272(30):18779-89. PubMed ID: 9228052
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dehydroepiandrosterone effects on the mRNA levels of peroxisome proliferator-activated receptors and their coactivators in human hepatoma HepG2 cells.
    Poczatková H; Bogdanová K; Uherková L; Cervenková K; Riegrová D; Rypka M; Veselý J
    Gen Physiol Biophys; 2007 Dec; 26(4):268-74. PubMed ID: 18281744
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chemopreventive effect of peroxisome proliferator-activated receptor gamma on gastric carcinogenesis in mice.
    Lu J; Imamura K; Nomura S; Mafune K; Nakajima A; Kadowaki T; Kubota N; Terauchi Y; Ishii G; Ochiai A; Esumi H; Kaminishi M
    Cancer Res; 2005 Jun; 65(11):4769-74. PubMed ID: 15930296
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rosiglitazone induces caveolin-1 by PPARgamma-dependent and PPRE-independent mechanisms: the role of EGF receptor signaling and its effect on cancer cell drug resistance.
    Tencer L; Burgermeister E; Ebert MP; Liscovitch M
    Anticancer Res; 2008; 28(2A):895-906. PubMed ID: 18507034
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 2-cyano-lup-1-en-3-oxo-20-oic acid, a cyano derivative of betulinic acid, activates peroxisome proliferator-activated receptor gamma in colon and pancreatic cancer cells.
    Chintharlapalli S; Papineni S; Liu S; Jutooru I; Chadalapaka G; Cho SD; Murthy RS; You Y; Safe S
    Carcinogenesis; 2007 Nov; 28(11):2337-46. PubMed ID: 17724373
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pioglitazone, a synthetic ligand for PPARgamma, induces apoptosis in RB-deficient human colorectal cancer cells.
    Lee CJ; Han JS; Seo CY; Park TH; Kwon HC; Jeong JS; Kim IH; Yun J; Bae YS; Kwak JY; Park JI
    Apoptosis; 2006 Mar; 11(3):401-11. PubMed ID: 16520894
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Revised genomic structure of the human ghrelin gene and identification of novel exons, alternative splice variants and natural antisense transcripts.
    Seim I; Collet C; Herington AC; Chopin LK
    BMC Genomics; 2007 Aug; 8():298. PubMed ID: 17727735
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of new acyl-CoA binding protein transcripts in human and mouse.
    Nitz I; Döring F; Schrezenmeir J; Burwinkel B
    Int J Biochem Cell Biol; 2005 Nov; 37(11):2395-405. PubMed ID: 16055366
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A peroxisome proliferator-activated receptor gamma antagonist induces vimentin cleavage and inhibits invasion in high-grade hepatocellular carcinoma.
    Kim KR; Choi HN; Lee HJ; Baek HA; Park HS; Jang KY; Chung MJ; Moon WS
    Oncol Rep; 2007 Oct; 18(4):825-32. PubMed ID: 17786342
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Abnormal expression of PPAR gamma isoforms in the subcutaneous adipose tissue of patients with Cushing's disease.
    Bogazzi F; Ultimieri F; Raggi F; Russo D; Manetti L; Cosci C; Sardella C; Costa A; Santini F; Locci T; Bartalena L; Martino E
    Clin Endocrinol (Oxf); 2007 Jan; 66(1):7-12. PubMed ID: 17201795
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Downregulation of cyclooxygenase-2 expression and activation of caspase-3 are involved in peroxisome proliferator-activated receptor-gamma agonists induced apoptosis in human monocyte leukemia cells in vitro.
    Liu JJ; Liu PQ; Lin DJ; Xiao RZ; Huang M; Li XD; He Y; Huang RW
    Ann Hematol; 2007 Mar; 86(3):173-83. PubMed ID: 17089125
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modulation of peroxisome proliferator-activated receptor delta and gamma transcripts in swine endometrial tissue during early gestation.
    Lord E; Murphy BD; Desmarais JA; Ledoux S; Beaudry D; Palin MF
    Reproduction; 2006 May; 131(5):929-42. PubMed ID: 16672357
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of one exon deletion of intestinal alkaline sphingomyelinase in colon cancer HT-29 cells and a differentiation-related expression of the wild-type enzyme in Caco-2 cells.
    Wu J; Cheng Y; Nilsson A; Duan RD
    Carcinogenesis; 2004 Aug; 25(8):1327-33. PubMed ID: 15016655
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Troglitazone inhibits synthesis of transforming growth factor-beta1 and reduces matrix production in human peritoneal mesothelial cells.
    Peng Y; Liu H; Liu F; Liu Y; Li J; Chen X
    Nephrology (Carlton); 2006 Dec; 11(6):516-23. PubMed ID: 17199790
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.